J&J's Weldon Challenges Use Of Evidence-Based Medicine For Policy Decisions

Cost "really has no place in a discussion about quality," outgoing chair Weldon tells the Pharmaceutical Research & Manufacturers of America annual meeting.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet